共 50 条
- [42] Dysregulation of miRNA in chronic hepatitis B is associated with HCC risk after nucleos( t) ide analogue treatment CANCER SCIENCE, 2018, 109 : 692 - 692
- [44] Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal JOURNAL OF INFECTIOUS DISEASES, 2024,
- [45] Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients PLOS ONE, 2015, 10 (06):
- [48] Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential Journal of Gastroenterology, 2013, 48 : 999 - 1005